303 related articles for article (PubMed ID: 21574189)
1. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.
Chu SC; Chiou HL; Chen PN; Yang SF; Hsieh YS
Mol Carcinog; 2004 Jul; 40(3):143-9. PubMed ID: 15224346
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
4. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.
Hsieh YS; Chu SC; Yang SF; Chen PN; Liu YC; Lu KH
Carcinogenesis; 2007 May; 28(5):977-87. PubMed ID: 17116726
[TBL] [Abstract][Full Text] [Related]
5. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
6. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
[TBL] [Abstract][Full Text] [Related]
7. Y27632 attenuates the aristolochic acid-promoted invasion and migration of human urothelial cancer TSGH cells in vitro and inhibits the growth of xenografts in vivo.
Huang HP; Wang CJ; Tsai JP; Wu SW; Hung TW; Lian JD; Chang HR
Nephrol Dial Transplant; 2012 Feb; 27(2):565-75. PubMed ID: 21799205
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
Zhang J; Wang B
Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
[TBL] [Abstract][Full Text] [Related]
9. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.
Lu Z; Lu N; Li C; Li F; Zhao K; Lin B; Guo Q
Toxicol Lett; 2012 Mar; 209(3):211-20. PubMed ID: 22245252
[TBL] [Abstract][Full Text] [Related]
10. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG
Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288
[TBL] [Abstract][Full Text] [Related]
11. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway.
Shih YW; Wu PF; Lee YC; Shi MD; Chiang TA
J Agric Food Chem; 2009 May; 57(9):3490-9. PubMed ID: 19326946
[TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
Chen PN; Hsieh YS; Chiou HL; Chu SC
Chem Biol Interact; 2005 Oct; 156(2-3):141-50. PubMed ID: 16169542
[TBL] [Abstract][Full Text] [Related]
13. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3.
Cheung CW; Vesey DA; Nicol DL; Johnson DW
BJU Int; 2007 Feb; 99(2):454-60. PubMed ID: 17313429
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells.
Chu SC; Yang SF; Liu SJ; Kuo WH; Chang YZ; Hsieh YS
Food Chem Toxicol; 2007 Jul; 45(7):1194-201. PubMed ID: 17303298
[TBL] [Abstract][Full Text] [Related]
17. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
[TBL] [Abstract][Full Text] [Related]
18. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9.
Ho YT; Yang JS; Li TC; Lin JJ; Lin JG; Lai KC; Ma CY; Wood WG; Chung JG
Cancer Lett; 2009 Jul; 279(2):155-62. PubMed ID: 19251361
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]